Skip to main content
NCBI home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1996 Apr-Jun;2(2):109–116. doi: 10.3201/eid0202.960205

Emerging disease issues and fungal pathogens associated with HIV infection.

N M Ampel 1
PMCID: PMC2639832  PMID: 8903210

Abstract

Fungal diseases are increasing among patients infected with human immunodeficiency virus (HIV) type 1. Infections due to Candida and Cryptococcus are the most common. Although mucocutaneous candidiasis can be treated with oral antifungal agents, increasing evidence suggests that prolonged use of these drugs results in both clinical and microbiologic resistance. The optimal therapy for cryptococcal meningitis remains unresolved, although initial treatment with amphotericin B, followed by life-long maintenance therapy with fluconazole, appears promising. Most cases of histoplasmosis, coccidioidomycosis, and blastomycosis occur in regions where their causative organisms are endemic, and increasing data suggest that a significant proportion of disease is due to recent infection. Aspergillosis is increasing dramatically as an opportunistic infection in HIV-infected patients, in part because of the increased incidence of neutropenia and corticosteroid use in these patients. Infection due to Penicillium marneffei is a rapidly growing problem among HIV-infected patients living in Southeast Asia. Although the advent of oral azole antifungal drugs has made primary prophylaxis against fungal diseases in HIV-infected patients feasible, many questions remain to be answered before the preventive use of antifungal drugs can be advocated.

Full Text

The Full Text of this article is available as a PDF (60.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ampel N. M., Dols C. L., Galgiani J. N. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med. 1993 Mar;94(3):235–240. doi: 10.1016/0002-9343(93)90054-s. [DOI] [PubMed] [Google Scholar]
  2. Antoniskis D., Larsen R. A., Akil B., Rarick M. U., Leedom J. M. Seronegative disseminated coccidioidomycosis in patients with HIV infection. AIDS. 1990 Jul;4(7):691–693. doi: 10.1097/00002030-199007000-00015. [DOI] [PubMed] [Google Scholar]
  3. Arguinchona H. L., Ampel N. M., Dols C. L., Galgiani J. N., Mohler M. J., Fish D. G. Persistent coccidioidal seropositivity without clinical evidence of active coccidioidomycosis in patients infected with human immunodeficiency virus. Clin Infect Dis. 1995 May;20(5):1281–1285. doi: 10.1093/clinids/20.5.1281. [DOI] [PubMed] [Google Scholar]
  4. Bozzette S. A., Larsen R. A., Chiu J., Leal M. A., Jacobsen J., Rothman P., Robinson P., Gilbert G., McCutchan J. A., Tilles J. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med. 1991 Feb 28;324(9):580–584. doi: 10.1056/NEJM199102283240902. [DOI] [PubMed] [Google Scholar]
  5. Centers for Disease Control and Prevention (CDC) Coccidioidomycosis following the Northridge Earthquake--California, 1994. MMWR Morb Mortal Wkly Rep. 1994 Mar 18;43(10):194–195. [PubMed] [Google Scholar]
  6. Chandenier J., Goma D., Moyen G., Samba-Lefèbvre M. C., Nzingoula S., Obengui, Mbitsi A., Nkiwabonga L., Ngaporo A. I. Histoplasmose africaine à Histoplasma capsulatum var. duboisii: liens avec le SIDA à propos de cas congolais récents. Sante. 1995 Jul-Aug;5(4):227–234. [PubMed] [Google Scholar]
  7. Denning D. W., Follansbee S. E., Scolaro M., Norris S., Edelstein H., Stevens D. A. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med. 1991 Mar 7;324(10):654–662. doi: 10.1056/NEJM199103073241003. [DOI] [PubMed] [Google Scholar]
  8. Denning D. W., Lee J. Y., Hostetler J. S., Pappas P., Kauffman C. A., Dewsnup D. H., Galgiani J. N., Graybill J. R., Sugar A. M., Catanzaro A. NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. Am J Med. 1994 Aug;97(2):135–144. doi: 10.1016/0002-9343(94)90023-x. [DOI] [PubMed] [Google Scholar]
  9. Dismukes W. E. Cryptococcal meningitis in patients with AIDS. J Infect Dis. 1988 Apr;157(4):624–628. doi: 10.1093/infdis/157.4.624. [DOI] [PubMed] [Google Scholar]
  10. Einstein H. E., Johnson R. H. Coccidioidomycosis: new aspects of epidemiology and therapy. Clin Infect Dis. 1993 Mar;16(3):349–354. doi: 10.1093/clind/16.3.349. [DOI] [PubMed] [Google Scholar]
  11. Fish D. G., Ampel N. M., Galgiani J. N., Dols C. L., Kelly P. C., Johnson C. H., Pappagianis D., Edwards J. E., Wasserman R. B., Clark R. J. Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine (Baltimore) 1990 Nov;69(6):384–391. doi: 10.1097/00005792-199011000-00006. [DOI] [PubMed] [Google Scholar]
  12. Huang C. T., McGarry T., Cooper S., Saunders R., Andavolu R. Disseminated histoplasmosis in the acquired immunodeficiency syndrome. Report of five cases from a nonendemic area. Arch Intern Med. 1987 Jun;147(6):1181–1184. [PubMed] [Google Scholar]
  13. Imam N., Carpenter C. C., Mayer K. H., Fisher A., Stein M., Danforth S. B. Hierarchical pattern of mucosal candida infections in HIV-seropositive women. Am J Med. 1990 Aug;89(2):142–146. doi: 10.1016/0002-9343(90)90291-k. [DOI] [PubMed] [Google Scholar]
  14. Jones J. L., Fleming P. L., Ciesielski C. A., Hu D. J., Kaplan J. E., Ward J. W. Coccidioidomycosis among persons with AIDS in the United States. J Infect Dis. 1995 Apr;171(4):961–966. doi: 10.1093/infdis/171.4.961. [DOI] [PubMed] [Google Scholar]
  15. Klapholz A., Salomon N., Perlman D. C., Talavera W. Aspergillosis in the acquired immunodeficiency syndrome. Chest. 1991 Dec;100(6):1614–1618. doi: 10.1378/chest.100.6.1614. [DOI] [PubMed] [Google Scholar]
  16. Klein B. S., Vergeront J. M., Weeks R. J., Kumar U. N., Mathai G., Varkey B., Kaufman L., Bradsher R. W., Stoebig J. F., Davis J. P. Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med. 1986 Feb 27;314(9):529–534. doi: 10.1056/NEJM198602273140901. [DOI] [PubMed] [Google Scholar]
  17. Klein R. S., Harris C. A., Small C. B., Moll B., Lesser M., Friedland G. H. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med. 1984 Aug 9;311(6):354–358. doi: 10.1056/NEJM198408093110602. [DOI] [PubMed] [Google Scholar]
  18. Larsen R. A., Leal M. A., Chan L. S. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. Ann Intern Med. 1990 Aug 1;113(3):183–187. doi: 10.7326/0003-4819-113-3-183. [DOI] [PubMed] [Google Scholar]
  19. Levitz S. M. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis. 1991 Nov-Dec;13(6):1163–1169. doi: 10.1093/clinids/13.6.1163. [DOI] [PubMed] [Google Scholar]
  20. Lortholary O., Meyohas M. C., Dupont B., Cadranel J., Salmon-Ceron D., Peyramond D., Simonin D. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS. Am J Med. 1993 Aug;95(2):177–187. doi: 10.1016/0002-9343(93)90258-q. [DOI] [PubMed] [Google Scholar]
  21. Mahaffey K. W., Hippenmeyer C. L., Mandel R., Ampel N. M. Unrecognized coccidioidomycosis complicating Pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus and treated with corticosteroids. A report of two cases. Arch Intern Med. 1993 Jun 28;153(12):1496–1498. [PubMed] [Google Scholar]
  22. McKinsey D. S., Gupta M. R., Riddler S. A., Driks M. R., Smith D. L., Kurtin P. J. Long-term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1989 Oct 15;111(8):655–659. doi: 10.7326/0003-4819-111-8-655. [DOI] [PubMed] [Google Scholar]
  23. Miller W. T., Jr, Sais G. J., Frank I., Gefter W. B., Aronchick J. M., Miller W. T. Pulmonary aspergillosis in patients with AIDS. Clinical and radiographic correlations. Chest. 1994 Jan;105(1):37–44. doi: 10.1378/chest.105.1.37. [DOI] [PubMed] [Google Scholar]
  24. Norris S., Wheat J., McKinsey D., Lancaster D., Katz B., Black J., Driks M., Baker R., Israel K., Traeger D. Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome. Am J Med. 1994 Jun;96(6):504–508. doi: 10.1016/0002-9343(94)90089-2. [DOI] [PubMed] [Google Scholar]
  25. Pappas P. G., Pottage J. C., Powderly W. G., Fraser V. J., Stratton C. W., McKenzie S., Tapper M. L., Chmel H., Bonebrake F. C., Blum R. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1992 May 15;116(10):847–853. doi: 10.7326/0003-4819-116-10-847. [DOI] [PubMed] [Google Scholar]
  26. Perfect J. R. Antifungal prophylaxis: to prevent or not. Am J Med. 1993 Mar;94(3):233–234. doi: 10.1016/0002-9343(93)90053-r. [DOI] [PubMed] [Google Scholar]
  27. Piehl M. R., Kaplan R. L., Haber M. H. Disseminated penicilliosis in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1988 Dec;112(12):1262–1264. [PubMed] [Google Scholar]
  28. Powderly W. G., Finkelstein D., Feinberg J., Frame P., He W., van der Horst C., Koletar S. L., Eyster M. E., Carey J., Waskin H. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med. 1995 Mar 16;332(11):700–705. doi: 10.1056/NEJM199503163321102. [DOI] [PubMed] [Google Scholar]
  29. Powderly W. G. Prophylaxis for HIV-related infections: a work in progress. Ann Intern Med. 1996 Feb 1;124(3):342–344. doi: 10.7326/0003-4819-124-3-199602010-00012. [DOI] [PubMed] [Google Scholar]
  30. Powderly W. G., Robinson K., Keath E. J. Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence. J Infect Dis. 1993 Aug;168(2):463–466. doi: 10.1093/infdis/168.2.463. [DOI] [PubMed] [Google Scholar]
  31. Powderly W. G., Saag M. S., Cloud G. A., Robinson P., Meyer R. D., Jacobson J. M., Graybill J. R., Sugar A. M., McAuliffe V. J., Follansbee S. E. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med. 1992 Mar 19;326(12):793–798. doi: 10.1056/NEJM199203193261203. [DOI] [PubMed] [Google Scholar]
  32. Redding S., Smith J., Farinacci G., Rinaldi M., Fothergill A., Rhine-Chalberg J., Pfaller M. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis. 1994 Feb;18(2):240–242. doi: 10.1093/clinids/18.2.240. [DOI] [PubMed] [Google Scholar]
  33. Salzman S. H., Smith R. L., Aranda C. P. Histoplasmosis in patients at risk for the acquired immunodeficiency syndrome in a nonendemic setting. Chest. 1988 May;93(5):916–921. doi: 10.1378/chest.93.5.916. [DOI] [PubMed] [Google Scholar]
  34. Sangeorzan J. A., Bradley S. F., He X., Zarins L. T., Ridenour G. L., Tiballi R. N., Kauffman C. A. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med. 1994 Oct;97(4):339–346. doi: 10.1016/0002-9343(94)90300-x. [DOI] [PubMed] [Google Scholar]
  35. Singh N., Yu V. L., Rihs J. D. Invasive aspergillosis in AIDS. South Med J. 1991 Jul;84(7):822–827. doi: 10.1097/00007611-199107000-00003. [DOI] [PubMed] [Google Scholar]
  36. Stevens D. A., Greene S. I., Lang O. S. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily. Arch Intern Med. 1991 Dec;151(12):2458–2464. [PubMed] [Google Scholar]
  37. Supparatpinyo K., Khamwan C., Baosoung V., Nelson K. E., Sirisanthana T. Disseminated Penicillium marneffei infection in southeast Asia. Lancet. 1994 Jul 9;344(8915):110–113. doi: 10.1016/s0140-6736(94)91287-4. [DOI] [PubMed] [Google Scholar]
  38. Supparatpinyo K., Sirisanthana T. Disseminated Penicillium marneffei infection diagnosed on examination of a peripheral blood smear of a patient with human immunodeficiency virus infection. Clin Infect Dis. 1994 Feb;18(2):246–247. doi: 10.1093/clinids/18.2.246. [DOI] [PubMed] [Google Scholar]
  39. Varma A., Swinne D., Staib F., Bennett J. E., Kwon-Chung K. J. Diversity of DNA fingerprints in Cryptococcus neoformans. J Clin Microbiol. 1995 Jul;33(7):1807–1814. doi: 10.1128/jcm.33.7.1807-1814.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Wheat J., Hafner R., Korzun A. H., Limjoco M. T., Spencer P., Larsen R. A., Hecht F. M., Powderly W. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group. Am J Med. 1995 Apr;98(4):336–342. doi: 10.1016/s0002-9343(99)80311-8. [DOI] [PubMed] [Google Scholar]
  41. Wheat J., Hafner R., Wulfsohn M., Spencer P., Squires K., Powderly W., Wong B., Rinaldi M., Saag M., Hamill R. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1993 Apr 15;118(8):610–616. doi: 10.7326/0003-4819-118-8-199304150-00006. [DOI] [PubMed] [Google Scholar]
  42. Wheat L. J., Connolly-Stringfield P. A., Baker R. L., Curfman M. F., Eads M. E., Israel K. S., Norris S. A., Webb D. H., Zeckel M. L. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990 Nov;69(6):361–374. doi: 10.1097/00005792-199011000-00004. [DOI] [PubMed] [Google Scholar]
  43. Wheat L. J., Connolly-Stringfield P., Blair R., Connolly K., Garringer T., Katz B. P., Gupta M. Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis. Am J Med. 1992 Feb;92(2):153–160. doi: 10.1016/0002-9343(92)90106-l. [DOI] [PubMed] [Google Scholar]
  44. Wheat L. J. Histoplasmosis in Indianapolis. Clin Infect Dis. 1992 Mar;14 (Suppl 1):S91–S99. doi: 10.1093/clinids/14.supplement_1.s91. [DOI] [PubMed] [Google Scholar]
  45. Wheat L. J., Slama T. G., Zeckel M. L. Histoplasmosis in the acquired immune deficiency syndrome. Am J Med. 1985 Feb;78(2):203–210. doi: 10.1016/0002-9343(85)90427-9. [DOI] [PubMed] [Google Scholar]
  46. Whelan W. L., Kirsch D. R., Kwon-Chung K. J., Wahl S. M., Smith P. D. Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel of hypervirulent strain. J Infect Dis. 1990 Aug;162(2):513–518. doi: 10.1093/infdis/162.2.513. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES